These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 31091164

  • 1. VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology.
    Jang H, Jang ER, Wilson PG, Anderson D, Galperin E.
    Mol Biol Cell; 2019 Jul 01; 30(14):1655-1663. PubMed ID: 31091164
    [Abstract] [Full Text] [Related]

  • 2. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS, Winter L, Strucksberg KH, Berwanger C, Türk M, Kornblum C, Florin A, Aguilar-Pimentel JA, Amarie OV, Becker L, Garrett L, Hans W, Moreth K, Neff F, Pingen L, Rathkolb B, Rácz I, Rozman J, Treise I, Fuchs H, Gailus-Durner V, de Angelis MH, Vorgerd M, Eichinger L, Schröder R.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2770-2777. PubMed ID: 30100055
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic variability in three families with valosin-containing protein mutation.
    Spina S, Van Laar AD, Murrell JR, Hamilton RL, Kofler JK, Epperson F, Farlow MR, Lopez OL, Quinlan J, DeKosky ST, Ghetti B.
    Eur J Neurol; 2013 Feb 18; 20(2):251-8. PubMed ID: 22900631
    [Abstract] [Full Text] [Related]

  • 4. Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy.
    Blythe EE, Olson KC, Chau V, Deshaies RJ.
    Proc Natl Acad Sci U S A; 2017 May 30; 114(22):E4380-E4388. PubMed ID: 28512218
    [Abstract] [Full Text] [Related]

  • 5. Valosin-Containing Protein (VCP)/p97 Oligomerization.
    Yu G, Bai Y, Zhang ZY.
    Subcell Biochem; 2024 May 30; 104():485-501. PubMed ID: 38963497
    [Abstract] [Full Text] [Related]

  • 6. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.
    Bartolome F, Wu HC, Burchell VS, Preza E, Wray S, Mahoney CJ, Fox NC, Calvo A, Canosa A, Moglia C, Mandrioli J, Chiò A, Orrell RW, Houlden H, Hardy J, Abramov AY, Plun-Favreau H.
    Neuron; 2013 Apr 10; 78(1):57-64. PubMed ID: 23498975
    [Abstract] [Full Text] [Related]

  • 7. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
    Itoh N, Nagai T, Watanabe T, Taki K, Nabeshima T, Kaibuchi K, Yamada K.
    Biochem Biophys Res Commun; 2017 Dec 02; 493(4):1384-1389. PubMed ID: 28970065
    [Abstract] [Full Text] [Related]

  • 8. Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants.
    Zhang T, Mishra P, Hay BA, Chan D, Guo M.
    Elife; 2017 Mar 21; 6():. PubMed ID: 28322724
    [Abstract] [Full Text] [Related]

  • 9. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC, Hung WT, Chang YC, Chang HC, Wu CL, Chiang AS, Jackson GR, Sang TK.
    PLoS Genet; 2011 Feb 03; 7(2):e1001288. PubMed ID: 21304887
    [Abstract] [Full Text] [Related]

  • 10. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C, Wang Q, Song C, Lockett SJ, Colburn NH, Li CC, Wang JM, Rogers TJ.
    Biochim Biophys Acta; 2015 Jan 03; 1853(1):222-32. PubMed ID: 25447673
    [Abstract] [Full Text] [Related]

  • 11. [Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia].
    Hayashi Y.
    Rinsho Shinkeigaku; 2013 Jan 03; 53(11):947-50. PubMed ID: 24291843
    [Abstract] [Full Text] [Related]

  • 12. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK, Neumann M, Lu H, Wright AC, Taylor JP.
    Hum Mol Genet; 2010 May 01; 19(9):1741-55. PubMed ID: 20147319
    [Abstract] [Full Text] [Related]

  • 13. Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes.
    Nandi P, Li S, Columbres RCA, Wang F, Williams DR, Poh YP, Chou TF, Chiu PL.
    Int J Mol Sci; 2021 Jul 28; 22(15):. PubMed ID: 34360842
    [Abstract] [Full Text] [Related]

  • 14. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS, Weihl CC.
    Hum Mol Genet; 2010 Apr 15; 19(R1):R38-45. PubMed ID: 20410287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE.
    J Mol Neurosci; 2011 Nov 15; 45(3):522-31. PubMed ID: 21892620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.
    Shinjo SK, Oba-Shinjo SM, Lerario AM, Marie SKN.
    Clin Rheumatol; 2018 Apr 15; 37(4):1129-1136. PubMed ID: 29127544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.